TB-500 + BPC-157 Wolverine blend

You can buy the BPC-157 + TB-500 blend (the ‘Wolverine mix’) from Peptide Lab as a lab-verified research blend with 99.0% purity, for research purposes only. This blend combines two of the most extensively studied regenerative peptides — BPC-157 and TB-500 — in a single vial, designed for synergistic research into regeneration, tendons and tissue. Each vial contains a total of 10 mg in the form of a lyophilised powder.

Who is this blend intended for?

This blend is intended for researchers and laboratories studying tissue and repair processes who wish to combine both peptides in a single setup. The individual variants can be found under BPC-157 and TB-500; see also the Recovery & Healing category and the comprehensive guide to recovery peptides.

Why Peptide Lab?

• Verified purity of 99.0% by HPLC and mass spectrometry.
• Batch documentation is available.
• Lyophilised powder, 10 mg in total per vial.
• Fast, discreet EU delivery.

This blend is not a medicine and is not intended for human or animal consumption.

Specifications at a glance

• Form: freeze-dried powder (blend)
• Packaging: 10 mg in total per vial
• Purity: 99.0%
• Molecular weight: See CoA
• Laboratory certificate: available on request
• For laboratory and research purposes only

This blend combines two peptides that are being studied for their different mechanisms of action. BPC-157 is a pentadecapeptide derived from a gastric protective protein; TB-500 is a fragment of Thymosin Beta-4 that is being investigated for its effects on actin regulation and cell migration.

Mechanism of action under investigation

As BPC-157 and TB-500 act via different mechanisms, they are sometimes combined in study set-ups to investigate a possible synergistic effect. This blend combines both in a single standardised product, which facilitates comparisons between experiments. The nickname ‘Wolverine mix’ refers to their combined focus on tissue repair in research.

This description relates to the mechanism of action as studied in research and does not constitute evidence of efficacy in humans.

Working with a blend has a practical advantage: both peptides are combined in a fixed ratio, which simplifies preparation and makes it easier to compare experiments with one another. At the same time, it requires careful interpretation, as an observed effect may stem from one component, the other, or both. This balance between ease of use and careful interpretation is a defining feature of working with blends.

BPC-157 and TB-500 are already among the most extensively studied recovery peptides in their own right; this blend combines them to investigate their combined effects.

• Research focus: tissue, tendon and joint processes (preclinical).
• Research focus: complementary mechanisms of BPC-157 and TB-500.
• Research focus: the practical value of a standardised blend.

Status and context

The blend and both individual components have not been authorised as medicinal products and are supplied solely as research materials. In a blend, the ratio between the two peptides is fixed; record this ratio and the batch number for each experiment to ensure traceability.

For researchers wishing to study the combined use of recovery peptides, the blend provides a standardised starting point. Comparing it with the individual components in separate experiments helps to determine the contribution of each peptide; be sure to record the fixed ratio and the batch number.

The blend is supplied as a lyophilised powder and reconstituted in the laboratory using bacteriostatic water. The steps below describe only the laboratory procedures for research purposes.

1. 1Allow the vial and the bacteriostatic water to reach room temperature.
2. 2Wipe the rubber stoppers of both vials with an alcohol wipe.
3. 3Allow the bacteriostatic water to run slowly down the side of the vial; do not direct it straight onto the powder.
4. 4Gently swirl the vial until everything has dissolved; do not shake.
5. 5Store the solution in the fridge and label it with the date and batch number.

This is a laboratory instruction and not a dosage recommendation for consumption.

Combining approaches in research

The blend is supplied as a lyophilised powder and reconstituted in the lab using bacteriostatic water. You can find the necessary supplies, such as bacteriostatic water, insulin syringes and alcohol wipes, under ‘Lab & Accessories’. Would you like to know more about the individual components? Read about what BPC-157 is or take a look at TB-500. Document each compound separately, specifying its purity and batch number, so that observations remain traceable.

Carry out the work in a standardised manner and document the method, concentration and batch number for each experiment. Prepare only the quantity you need in the short term.

Store the blend in freeze-dried (powder) form in a cool, dark place for maximum stability.

Practical storage tips

• Powder form: freezer (-20 °C) for long-term storage; fridge (2–8 °C) for short-term storage.
• After reconstitution: store refrigerated (2–8 °C) and use within a few weeks.
• Avoid direct light, heat and repeated temperature changes.
• Write the reconstitution date and batch number on the vial.

Consistent, cold and dark storage ensures reliable, reproducible measurement results across experiments.

Check the solution for clarity before use.